Malignant Hyperthermia Questions & Answers

1. Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth. 2011 Jul. 107 (1):48-56. [QxMD MEDLINE Link].

2. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990 Feb 8. 343 (6258):559-61. [QxMD MEDLINE Link].

3. Schneiderbanger D, Johannsen S, Roewer N, Schuster F. Management of malignant hyperthermia: diagnosis and treatment. Ther Clin Risk Manag. 2014. 10:355-62. [QxMD MEDLINE Link]. [Full Text].

4. Harrison GG. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth. 1975 Jan. 47 (1):62-5. [QxMD MEDLINE Link].

5. Kolb ME, Horne ML, Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology. 1982 Apr. 56 (4):254-62. [QxMD MEDLINE Link].

6. MacLennan DH. The genetic basis of malignant hyperthermia. Trends Pharmacol Sci. 1992 Aug. 13 (8):330-4. [QxMD MEDLINE Link].

7. Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesthesiology. 2008 Apr. 108 (4):603-11. [QxMD MEDLINE Link].

8. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994 Apr. 80 (4):771-9. [QxMD MEDLINE Link].

9. Isaacs H, Badenhorst ME. Dominantly inherited malignant hyperthermia (MH) in the King-Denborough syndrome. Muscle Nerve. 1992 Jun. 15 (6):740-2. [QxMD MEDLINE Link].

10. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006 Oct. 27 (10):977-89. [QxMD MEDLINE Link].

11. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth. 2008 Feb. 18 (2):100-6. [QxMD MEDLINE Link].

12. Metterlein T, Hartung E, Schuster F, Roewer N, Anetseder M. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. Minerva Anestesiol. 2011 Aug. 77 (8):768-73. [QxMD MEDLINE Link].

13. Glahn KPE, Bendixen D, Girard T, Hopkins PM, Johannsen S, Rüffert H, et al. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. Br J Anaesth. 2020 Jun 23. [QxMD MEDLINE Link].

James W Chapin, MD Professor Emeritus, Department of Anesthesiology, University of Nebraska Medical Center

James W Chapin, MD is a member of the following medical societies: American Medical Association, American Society of Anesthesiologists, American Society of Regional Anesthesia and Pain Medicine, International Anesthesia Research Society, Nebraska Medical Association, Society of Cardiovascular Anesthesiologists, International Liver Transplantation Society

Disclosure: Nothing to disclose.

John Geibel, MD, MSc, DSc, AGAF Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, Professor, Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital; American Gastroenterological Association Fellow; Fellow of the Royal Society of Medicine

John Geibel, MD, MSc, DSc, AGAF is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

Burt Cagir, MD, FACS Assistant Professor of Surgery, State University of New York Upstate Medical University; Consulting Staff, Director of Surgical Research, Robert Packer Hospital; Associate Program Director, Department of Surgery, Guthrie Clinic

Burt Cagir, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, Association of Program Directors in Surgery, and Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Acknowledgments

The author wishes to acknowledge Phyllis Chapin for her technical assistance.

• Print this section
• Print the entire contents of
• Print the entire contents of article